MedTrace Logo

Anti-inflammatory Markers in Endometrioma

NCT04371133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2020-05-01

No results posted yet for this study

Summary

Investigators aimed to measure the serum levels of adropin, salusin-α, netrin-1, and nesfatin-1, anti-inflammatory effects of which have been demonstrated previously, in endometriosis patients and to find out any association of them with insulin resistance.

Conditions

Interventions

DIAGNOSTIC_TEST

Adropin (ng/L)

Thawed samples were measured on a Molecular Devices SpectraMax i3 Multi-Mode, Microplate Reader (batch number: SER 35 370-1448, made in Austria) using enzyme linked immunosorbent assay (ELISA).

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Burak Sezgin, Dr · Mugla Sıtkı Kocman University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-02-15
Completion
2020-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04371133 on ClinicalTrials.gov